Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate

I. Badiu, S. Sciascia, E. Heffler, G. Guida, F. De Renzis, C. Quaccia, L. Bommarito, C. Bucca, G. Rolla, L. Brussino (Turin, Italy)

Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Session: Biomarkers and diagnosis of allergic inflammatory diseases
Session type: Oral Presentation
Number: 5352
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Badiu, S. Sciascia, E. Heffler, G. Guida, F. De Renzis, C. Quaccia, L. Bommarito, C. Bucca, G. Rolla, L. Brussino (Turin, Italy). Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate. Eur Respir J 2010; 36: Suppl. 54, 5352

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007



Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007


Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 577s
Year: 2004

Levels of 8-isoprostane and LTB4 in exhaled breath condensate (EBC) in seasonal allergic rhinitis. Effect of therapy and allergen exposure
Source: Eur Respir J 2004; 24: Suppl. 48, 678s
Year: 2004

Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 680s
Year: 2004

Exhaled breath condensate: 8-isoprostane and eicosanoids
Source: Eur Respir Monogr 2010; 49: 196-206
Year: 2010


Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction
Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Year: 2011


Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Source: Eur Respir J 2004; 24: 1011-1017
Year: 2004



Inflammatory mediators in exhaled breath condensate, induced sputum and saliva
Source: Eur Respir J 2004; 24: Suppl. 48, 678s
Year: 2004

Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004